ArticlePediatric research2026
Urolithin A attenuates inflammation and enhances barrier integrity in an experimental NEC-in-a-Dish model.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Goldilocks zone of optimal antimicrobial stewardship in preterm infants.Pediatric research · 2026Article
- Inhibition of DNA demethylation attenuates experimental necrotizing enterocolitis via suppression of TLR4-mediated inflammation.Research square · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
background and hypothesisNecrotizing enterocolitis (NEC) is a devastating gastrointestinal disease in preterm infants, characterized by exaggerated inflammation and poorly understood pathogenesis. Aryl hydrocarbon receptor (AhR) signaling has been shown to reduce intestinal inflammation in colitis models. In these models, a microbial-derived AhR ligand, Urolithin A (UroA), has demonstrated anti-inflammatory properties and improved gut barrier function. We hypothesize that UroA attenuates inflammation and enhances epithelial barrier integrity in an in vitro NEC-in-a-Dish model.
methodsEnteroids derived from human neonatal intestinal tissue were pretreated with 100 µM UroA or 0.1% DMSO (vehicle) before a 6-h incubation with dysbiotic enteric bacteria cultured from an infant with NEC totalis (NEC-in-a-Dish). RNA sequencing was performed and analyzed for pro-inflammatory cytokine expression and pathway enrichment. Epithelial barrier integrity was evaluated using a fluorescein-isothiocyanate-dextran permeability assay on two-dimensional monolayers.
resultsUroA pretreatment decreased pro-inflammatory cytokine expression and enhanced barrier integrity. Transcriptomic analysis showed downregulation of NOD-like receptor, IL-17/Th17, NF-κB, and TLR signaling, and upregulation of AhR-dependent genes involved in antioxidant responses.
conclusionUroA reduces inflammation and strengthens epithelial barrier integrity in a NEC-in-a-Dish model through a variety of mechanisms. These findings support further investigation of dietary-derived metabolites as potential preventative strategies for NEC in preterm infants. IMPACT: Urolithin A (UroA), a microbiota-derived metabolite, reduces inflammation and enhances epithelial barrier integrity in a human neonatal in vitro model of necrotizing enterocolitis (NEC). This study is the first to demonstrate the protective effects of UroA in the neonatal small intestinal epithelium using a NEC-in-a-Dish model system. It also expands on the current understanding of the mechanism of action of UroA by revealing modulation of key inflammatory and oxidative stress pathways in neonatal tissue. These findings identify UroA as a promising candidate for dietary-based prevention strategies targeting epithelial injury in NEC.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.